Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Nature Medicine|December 28, 2010
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectinWilliam L Holland, Russell A Miller, Zhao V Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia geneR B Amson, M Nemani, J P Roperch, et al.
Journal of Lipid Research|May 10, 2018
Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IRFrode Norheim, Thomas Bjellaas, Simon T Hui, et al.
Cancer Research|April 19, 2017
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic StrategiesMai H Bui, Xiaoyu Lin, Daniel H Albert, et al.
Cancer Research|September 28, 2014
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic propertiesMarie Stampe Ostenfeld, Dennis K Jeppesen, Jens R Laurberg, et al.
Journal of Lipid Research|June 23, 2019
Rare DEGS1 variant significantly alters de novo ceramide synthesis pathwayNicholas B Blackburn, Laura F Michael, Peter J Meikle, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesKeith B Glaser, Junling Li, Patrick A Marcotte, et al.
Stem Cells Translational Medicine|June 3, 2021
Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cellsLiem Thanh Nguyen, Duc M Hoang, Kien T Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2018
Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitorsSteven D Fidanze, Dachun Liu, Robert A Mantei, et al.
Molecular Cancer Therapeutics|July 13, 2021
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid LeukemiaLu Zhang, Tianyu Cai, Xiaoyu Lin, et al.
Pageof 29